Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesshematopoietic progenitor cell differentiation

ACE SP1 SP3 PRRC2C

3.47e-05197204GO:0002244
GeneOntologyBiologicalProcessembryonic process involved in female pregnancy

SP1 SP3

4.00e-0510202GO:0060136
GeneOntologyBiologicalProcessmyeloid progenitor cell differentiation

SP1 SP3

8.07e-0514202GO:0002318
GeneOntologyBiologicalProcessenucleate erythrocyte differentiation

SP1 SP3

1.06e-0416202GO:0043353
GeneOntologyBiologicalProcessembryonic placenta development

SP1 SP3 SETD2

1.99e-04119203GO:0001892
GeneOntologyBiologicalProcesstrophectodermal cell differentiation

SP1 SP3

2.86e-0426202GO:0001829
GeneOntologyBiologicalProcessdefinitive hemopoiesis

SP1 SP3

3.09e-0427202GO:0060216
GeneOntologyBiologicalProcessembryonic skeletal system development

SP1 SP3 SETD2

3.77e-04148203GO:0048706
GeneOntologyBiologicalProcessembryonic camera-type eye morphogenesis

SP1 SP3

4.35e-0432202GO:0048596
GeneOntologyBiologicalProcesscoronary vasculature morphogenesis

ACE SETD2

4.92e-0434202GO:0060977
GeneOntologyBiologicalProcesscamera-type eye morphogenesis

ALMS1 SP1 SP3

5.75e-04171203GO:0048593
GeneOntologyBiologicalProcessembryonic eye morphogenesis

SP1 SP3

6.15e-0438202GO:0048048
GeneOntologyBiologicalProcesscamera-type eye development

ALMS1 LMX1B SP1 SP3

6.69e-04426204GO:0043010
GeneOntologyBiologicalProcessembryonic camera-type eye development

SP1 SP3

8.62e-0445202GO:0031076
GeneOntologyBiologicalProcessplacenta development

SP1 SP3 SETD2

8.68e-04197203GO:0001890
GeneOntologyBiologicalProcesseye morphogenesis

ALMS1 SP1 SP3

9.60e-04204203GO:0048592
GeneOntologyBiologicalProcesseye development

ALMS1 LMX1B SP1 SP3

1.04e-03480204GO:0001654
GeneOntologyBiologicalProcessvisual system development

ALMS1 LMX1B SP1 SP3

1.07e-03483204GO:0150063
GeneOntologyBiologicalProcesssensory system development

ALMS1 LMX1B SP1 SP3

1.14e-03491204GO:0048880
DomainSp1_fam

SP1 SP3 SP4

1.25e-0710203IPR030450
DomainZINC_PROTEASE

MMP26 ACE

4.87e-0398202PS00142
PathwayWP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE

SP1 SP3

1.37e-055172M45554
PathwayBIOCARTA_TERC_PATHWAY

SP1 SP3

2.05e-056172MM1564
PathwayBIOCARTA_TERC_PATHWAY

SP1 SP3

2.05e-056172M22047
PathwayBIOCARTA_TERT_PATHWAY

SP1 SP3

2.86e-057172MM1541
PathwayBIOCARTA_TERT_PATHWAY

SP1 SP3

3.82e-058172M22015
PathwayBIOCARTA_CALCINEURIN_PATHWAY

SP1 SP3

2.07e-0418172M3430
PathwayBIOCARTA_CALCINEURIN_PATHWAY

SP1 SP3

2.07e-0418172MM1385
PathwayWP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS

LMX1B SP1 SP3

8.52e-04159173M39373
PathwayWP_SELENIUM_METABOLISM_SELENOPROTEINS

SP1 SP3

1.31e-0345172MM15877
PathwayWP_MECP2_AND_ASSOCIATED_RETT_SYNDROME

SP1 SP3

1.37e-0346172MM15949
PathwayWP_SELENIUM_METABOLISM_AND_SELENOPROTEINS

SP1 SP3

1.43e-0347172M48301
PathwayWP_SIDS_SUSCEPTIBILITY_PATHWAYS

LMX1B SP1

2.25e-0359172MM15838
Pubmed

Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms.

SP1 SP3 SP4

1.63e-10320323540600
Pubmed

Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.

SP1 SP3 SP4

1.63e-10320326967243
Pubmed

Curcumin decreases specificity protein expression in bladder cancer cells.

SP1 SP3 SP4

1.63e-10320318593936
Pubmed

Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene.

SP1 SP3 SP4

1.63e-10320311532028
Pubmed

Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.

SP1 SP3 SP4

1.63e-10320321919647
Pubmed

Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3.

SP1 SP3 SP4

1.63e-1032037559627
Pubmed

Sp4 is expressed in retinal neurons, activates transcription of photoreceptor-specific genes, and synergizes with Crx.

SP1 SP3 SP4

6.50e-10420315781457
Pubmed

Sp2 is the only glutamine-rich specificity protein with minor impact on development and differentiation in myelinating glia.

SP1 SP3 SP4

6.50e-10420327889927
Pubmed

Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.

SP1 SP3 SP4

1.62e-09520320538607
Pubmed

Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.

SP1 SP3 SP4

1.62e-09520310547281
Pubmed

Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors.

SP1 SP3 SP4

1.62e-09520312560508
Pubmed

Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells.

SP1 SP3 SP4

3.25e-09620316201967
Pubmed

POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.

SP1 SP3 SP4

5.68e-09720312004059
Pubmed

Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure.

SP1 SP3

3.14e-07220210825178
Pubmed

HPV8 activates cellular gene expression mainly through Sp1/3 binding sites.

SP1 SP3

3.14e-07220231299490
Pubmed

Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia.

SP1 SP4

3.14e-07220225175639
Pubmed

Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1.

SP1 SP3

3.14e-07220214766015
Pubmed

Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function.

SP1 SP3

3.14e-07220225538045
Pubmed

Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors.

SP1 SP3

3.14e-07220231164147
Pubmed

Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.

SP1 SP3

3.14e-07220217681019
Pubmed

Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice.

SP1 SP3

3.14e-07220237735515
Pubmed

Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells.

SP1 SP3

3.14e-07220226807725
Pubmed

An Sp1/Sp3 binding polymorphism confers methylation protection.

SP1 SP3

3.14e-07220218725933
Pubmed

Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.

SP1 SP3

3.14e-07220215951564
Pubmed

Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene.

SP1 SP3

3.14e-07220222464952
Pubmed

Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells.

SP1 SP3

3.14e-07220219437621
Pubmed

Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3.

SP1 SP3

3.14e-0722028845379
Pubmed

Transcriptional control of human CD2AP expression: the role of Sp1 and Sp3.

SP1 SP3

3.14e-07220221604172
Pubmed

Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.

SP3 SP4

3.14e-0722021454515
Pubmed

Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3.

SP1 SP3

3.14e-07220221248046
Pubmed

Sp1 and Sp3 activate transcription of the human dopamine transporter gene.

SP1 SP3

3.14e-07220215816870
Pubmed

Sp family transcription factors regulate expression of rat D2 dopamine receptor gene.

SP1 SP3

3.14e-0722029628590
Pubmed

The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells.

SP1 SP3

3.14e-07220214608051
Pubmed

Reduced expression of SP1 and SP4 transcription factors in peripheral blood mononuclear cells in first-episode psychosis.

SP1 SP4

3.14e-07220223941741
Pubmed

Differentiation-dependent and cell-specific regulation of the hIGFBP-1 gene in human endometrium.

SP1 SP3

3.14e-0722029329821
Pubmed

Mammalian SP/KLF transcription factors: bring in the family.

SP1 SP3 SP4

3.71e-072520315820306
Pubmed

Expression of the human melanocortin-4 receptor gene is controlled by several members of the Sp transcription factor family.

SP1 SP3

9.42e-07320215821099
Pubmed

Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3.

SP1 SP3

9.42e-07320217652716
Pubmed

Regulation of human CETP gene expression: role of SP1 and SP3 transcription factors at promoter sites -690, -629, and -37.

SP1 SP3

9.42e-07320212730302
Pubmed

Expression patterns of SP1 and SP3 during mouse spermatogenesis: SP1 down-regulation correlates with two successive promoter changes and translationally compromised transcripts.

SP1 SP3

9.42e-07320218417714
Pubmed

Sp1 and Sp3 are involved in up-regulation of human deoxyribonuclease II transcription during differentiation of HL-60 cells.

SP1 SP3

9.42e-07320212694199
Pubmed

Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1.

SP1 SP3

9.42e-07320214701757
Pubmed

Regulation of the human secretin gene is controlled by the combined effects of CpG methylation, Sp1/Sp3 ratio, and the E-box element.

SP1 SP3

9.42e-07320215118068
Pubmed

Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors.

SP1 SP3

9.42e-07320217317039
Pubmed

In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3.

SP1 SP3

9.42e-07320211850421
Pubmed

Transcription factors sp1 and sp3 regulate expression of human extracellular superoxide dismutase in lung fibroblasts.

SP1 SP3

9.42e-07320218314536
Pubmed

Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

SP1 SP3

9.42e-07320211274368
Pubmed

Angiotensin-converting enzyme inhibitor promotes angiogenesis through Sp1/Sp3-mediated inhibition of notch signaling in male mice.

SP1 SP3

9.42e-07320236759621
Pubmed

Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells.

SP1 SP3

9.42e-07320216529657
Pubmed

Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter.

SP1 SP3

9.42e-07320211237613
Pubmed

Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.

SP1 SP3

9.42e-07320223028678
Pubmed

Sp proteins and Runx2 mediate regulation of matrix gla protein (MGP) expression by parathyroid hormone.

SP1 SP3

9.42e-07320219306294
Pubmed

Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells.

SP1 SP3

9.42e-07320215247906
Pubmed

Identification of an Sp factor-dependent promoter in GCET, a gene expressed at high levels in germinal center B cells.

SP1 SP3

9.42e-07320215482850
Pubmed

Involvement of Sp1/Sp3 in the activation of the GATA-1 erythroid promoter in K562 cells.

SP1 SP3

9.42e-07320218195733
Pubmed

Transcriptional regulation of the mouse gene encoding the alpha-4 subunit of the GABAA receptor.

SP3 SP4

9.42e-07320215265862
Pubmed

Structural and functional characterization of the mouse tescalcin promoter.

SP1 SP3

9.42e-07320220540995
Pubmed

Transcriptional regulation of the human CD97 promoter by Sp1/Sp3 in smooth muscle cells.

SP1 SP3

9.42e-07320218329191
Pubmed

Human glycolipid transfer protein gene (GLTP) expression is regulated by Sp1 and Sp3: involvement of the bioactive sphingolipid ceramide.

SP1 SP3

9.42e-07320220974858
Pubmed

Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene.

SP1 SP3

9.42e-07320212799440
Pubmed

The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoter.

SP1 SP3

9.42e-07320216672217
Pubmed

Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr-1.

SP1 SP3

9.42e-07320215523672
Pubmed

Transcription of the LAT gene is regulated by multiple binding sites for Sp1 and Sp3.

SP1 SP3

9.42e-07320218343609
Pubmed

Cell confluency-induced Stat3 activation regulates NHE3 expression by recruiting Sp1 and Sp3 to the proximal NHE3 promoter region during epithelial dome formation.

SP1 SP3

9.42e-07320219064501
Pubmed

Human Telomerase Reverse Transcriptase (hTERT) Transcription Requires Sp1/Sp3 Binding to the Promoter and a Permissive Chromatin Environment.

SP1 SP3

9.42e-07320226487723
Pubmed

Role of Sp1 and Sp3 in the nutrient-regulated expression of the human asparagine synthetase gene.

SP1 SP3

9.42e-07320211867623
Pubmed

Regulation of telomerase activity in Jurkat T cells by transcription factors Sp1 and Sp3.

SP1 SP3

9.42e-07320212297462
Pubmed

Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.

SP1 SP3

9.42e-07320226352013
Pubmed

Sp1 and Sp3 Are important regulators of AP-2gamma gene transcription.

SP1 SP3

9.42e-07320212801994
Pubmed

Activation of the RNA-dependent protein kinase PKR promoter in the absence of interferon is dependent upon Sp proteins.

SP1 SP3

9.42e-07320216339759
Pubmed

Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene.

SP1 SP3

9.42e-07320226162987
Pubmed

Involvement of the GC-rich sequence and specific proteins (Sp1/Sp3) in the basal transcription activity of neurogranin gene.

SP1 SP3

9.42e-07320216677608
Pubmed

Bifunctional properties of peroxisome proliferator-activated receptor gamma1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3.

SP1 SP3

9.42e-07320215111490
Pubmed

Sp1 and Sp3 mediate basal and serum-induced expression of human CENP-W.

SP1 SP3

9.42e-07320220180024
Pubmed

Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation.

SP1 SP3

9.42e-07320212855685
Pubmed

Murine glypican-4 gene structure and expression; Sp1 and Sp3 play a major role in glypican-4 expression in 3T3-F442A cells.

SP1 SP3

9.42e-07320215297147
Pubmed

Accessible chromatin structure permits factors Sp1 and Sp3 to regulate human TGFBI gene expression.

SP1 SP3

9.42e-07320221554857
Pubmed

Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.

SP1 SP3

9.42e-07320215451065
Pubmed

Molecular and functional characterization of the murine ldh2 promoter region: Sp-binding GC-box domains are the key cis-elements regulating ldh2 gene expression during spermatogenesis.

SP1 SP3

9.42e-07320218790003
Pubmed

Transcription of human β4-galactosyltransferase 3 is regulated by differential DNA binding of Sp1/Sp3 in SH-SY5Y human neuroblastoma and A549 human lung cancer cell lines.

SP1 SP3

9.42e-07320230561605
Pubmed

Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.

SP1 SP3

9.42e-07320212378384
Pubmed

The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid.

SP1 SP3

9.42e-07320215466927
Pubmed

Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements.

SP1 SP3

9.42e-07320212509426
Pubmed

Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.

SP1 SP3

9.42e-07320216052479
Pubmed

Sp1 and Sp3 transcription factors regulate the basal expression of human microsomal epoxide hydrolase (EPHX1) through interaction with the E1b far upstream promoter.

SP1 SP3

9.42e-07320224315822
Pubmed

Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-gamma/TNF-alpha.

SP1 SP3

9.42e-07320217540780
Pubmed

SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium.

SP1 SP3

9.42e-07320216807381
Pubmed

IFN-gamma and TNF-alpha regulate human NHE3 gene expression by modulating the Sp family transcription factors in human intestinal epithelial cell line C2BBe1.

SP1 SP3

9.42e-07320216760259
Pubmed

Regulation of the poly(ADP-ribose) polymerase-1 gene expression by the transcription factors Sp1 and Sp3 is under the influence of cell density in primary cultured cells.

SP1 SP3

9.42e-07320215777284
Pubmed

Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins.

SP1 SP3

9.42e-07320210816575
Pubmed

The HIV-Tat protein interacts with Sp3 transcription factor and inhibits its binding to a distal site of the sod2 promoter in human pulmonary artery endothelial cells.

SP1 SP3

9.42e-07320231863909
Pubmed

Transcriptional regulation of human FE65, a ligand of Alzheimer's disease amyloid precursor protein, by Sp1.

SP1 SP3

9.42e-07320220091743
Pubmed

Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors.

SP1 SP3

9.42e-07320223523134
Pubmed

O-GlcNAc modification of Sp3 and Sp4 transcription factors negatively regulates their transcriptional activities.

SP3 SP4

9.42e-07320226431879
Pubmed

Sp1 and Sp3 are involved in the full transcriptional activity of centromere protein H in human nasopharyngeal carcinoma cells.

SP1 SP3

9.42e-07320222682030
Pubmed

The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells.

SP1 SP3

9.42e-07320217906119
Pubmed

A crucial role for the ubiquitously expressed transcription factor Sp1 at early stages of hematopoietic specification.

SP1 SP3

9.42e-07320224850855
Pubmed

HIV-1 Tat regulates the SOD2 basal promoter by altering Sp1/Sp3 binding activity.

SP1 SP3

9.42e-07320215706661
Pubmed

NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.

SP1 SP3

9.42e-07320216671893
Pubmed

Physiological TLR5 expression in the intestine is regulated by differential DNA binding of Sp1/Sp3 through simultaneous Sp1 dephosphorylation and Sp3 phosphorylation by two different PKC isoforms.

SP1 SP3

9.42e-07320227060138
InteractionSP4 interactions

SP1 SP3 SP4

1.23e-0546203int:SP4
InteractionNKX3-1 interactions

SP1 SP3 SP4

1.79e-0552203int:NKX3-1
InteractionFHL2 interactions

ALMS1 SP1 SP3 SP4 PRRC2C

3.47e-05396205int:FHL2
InteractionSP3 interactions

SP1 SP3 SP4

7.57e-0584203int:SP3
InteractionZNF146 interactions

MMP26 SP1 PMEL

9.60e-0591203int:ZNF146
InteractionSPANXN2 interactions

ALMS1 SP3 SP4

1.09e-0495203int:SPANXN2
CytobandEnsembl 112 genes in cytogenetic band chr12q13

SP1 PMEL

1.44e-02423202chr12q13
GeneFamilyZinc fingers C2H2-type|Sp transcription factors

SP1 SP3 SP4

4.76e-089163755
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500

SP1 SP3 SP4 PRRC2C RESF1

2.24e-05403195gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500

CLIP4 SP1 SP3 RESF1

3.39e-04387194gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500

SP1 SP3 PRRC2C RESF1

3.66e-04395194gudmap_developingGonad_P2_epididymis_500
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500

SP1 SP3 PRRC2C RESF1

3.99e-04404194gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500

SP1 SP3 PRRC2C RESF1

4.06e-04406194gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200

SP3 PRRC2C RESF1

4.15e-04166193gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500

SP1 SP3 PRRC2C RESF1

4.34e-04413194gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000

CLIP4 SP1 SP3 PRRC2C RESF1

4.71e-04770195gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000

ALMS1 SP1 SP3 SP4 RESF1

4.88e-04776195gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000

CLIP4 SP1 SP3 PRRC2C RESF1

4.94e-04778195gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000

CLIP4 SP1 SP3 PRRC2C RESF1

5.45e-04795195gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000

SP1 SP3 SP4 PRRC2C RESF1

5.51e-04797195gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000

SP1 SP3 SP4 PRRC2C RESF1

5.64e-04801195gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000

SP1 SP3 SP4 PRRC2C RESF1

5.80e-04806195gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

ALMS1 TIGIT LMX1B IL36G SP4 BTAF1

5.91e-041257196facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_200

SP1 RESF1

6.39e-0442192gudmap_developingGonad_e12.5_epididymis_k1_200
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500

SP1 RESF1

1.02e-0353192gudmap_developingGonad_P2_epididymis_500_k4
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

ALMS1 SP1 SP3 RESF1

1.30e-0618620403db813598b67b1e08f759758a1c2023396921fa
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PRRC2C SETD2 BTAF1 RESF1

1.74e-0620020412f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellfacs-Large_Intestine-Distal-24m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TIGIT LMX1B IL36G

1.49e-05108203fcc26843a8788f0fe3cec14dcae083830da80b8f
ToppCellfacs-Large_Intestine-Distal-24m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TIGIT LMX1B IL36G

1.49e-05108203c1c68e328fdf5216f23845b4de9a3b1bbe61b11c
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TIGIT LMX1B RESF1

3.59e-05145203734d85ca7a2e5e040f433cadc5f9be1f25cf2e91
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TIGIT LMX1B RESF1

3.59e-051452038ba09eb0fd27f25aa90a3ad75d67a9f79f3f4f43
ToppCelldroplet-Liver-LIVER_NPC-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACE WDFY4 IL36G

4.64e-0515820390ca742739a208d457db087655ba3d1c18a9da57
ToppCelldroplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACE WDFY4 IL36G

4.81e-051602038dae9b0cf90a09acb196223f45a14680102630b2
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9

SP1 SETD2 RESF1

5.37e-0516620332d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCellfacs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP3 PRRC2C RESF1

6.07e-05173203869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCellfacs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP3 PRRC2C RESF1

6.07e-051732030672bd8a4a9d18af343d01f09253fb3388896c10
ToppCellfacs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP3 PRRC2C RESF1

6.07e-05173203870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

CLIP4 TIGIT RESF1

7.17e-051832035fb933acfe6bc555c90dba71e75d4be658763945
ToppCellT_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

TIGIT PMEL RESF1

8.92e-05197203de5448fcdf4e433fc167496413abe5d0c8a5c6d8
ToppCellCOVID-19|World / Disease, condition lineage and cell class

PRRC2C SETD2 RESF1

9.33e-052002037dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Tmem2_(Pdgfa)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

5.67e-0479202cd182dbc8d0ccc2406e78c9ba71476c1f463359b
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Tmem2_(Pdgfa)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

5.67e-0479202bcb9181d7de7a385b890523299f8290836aa536e
ToppCellSubstantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

5.81e-04802020d02b242164d27f38f70ed77b106612fc7a3abca
ToppCellSubstantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Tmem2_(Tmem2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

5.81e-0480202b95e4456adb7f7d42825351f010376c10bb35380
ToppCellSubstantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

5.81e-0480202313344cf7309bc17ca131b92a91b24489df577e2
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

LMX1B CNKSR3

5.96e-048120220796e59cdeb398e7772f4356578d74a33405f71
ToppCellFrontal_cortex-Macroglia-POLYDENDROCYTE-P1-P1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

6.40e-0484202db96d45e863d04a9b340c9229576d654dce85a3f
ToppCellFrontal_cortex-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

6.40e-0484202152807da52b50713fc6fed2b2bef5d5762e9c0da
ToppCellFrontal_cortex-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

6.40e-0484202a88bdb8ea8a50df38fb740515d02aa87293e5d25
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

6.56e-0485202159b3ac93490c3e4918ea61f8ede7add9e63ca40
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P1-P1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

7.51e-049120283564e9e4122c176a28c30b0c2546c82185ddaa6
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Hippocampus / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

7.51e-0491202ff6022b23e9bd8af24bcb658ae2b48eae6bf1e28
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Pdgfa_(Pdgfa)|Hippocampus / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

7.51e-04912024d84281e8e3236c687b910cd76de836b70dafdb7
ToppCellLA-06._Ventricular_Cardiomyocyte_II|LA / Chamber and Cluster_Paper

YIPF2 PMEL

7.67e-0492202fad2e02ae858e3a9bbe51ad1c689f7e31d11ce0e
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocye.Tnr.Pdgfa_(Pdgfa)|Striatum / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

8.70e-049820226250ea4171a0557a67505839cf79d3fe4d9d41a
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

8.70e-049820242875d16ae9fcbaf988cd71be82568f2f862f2dd
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P1-P1_2|Striatum / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

8.70e-04982027a62a77ca83153dacff4d02d6e32104227d0980d
ToppCellLPS-IL1RA-Endothelial-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ACE SP1

1.21e-03116202cf4e3c34570f57502ec524881d351ef8e47976d2
ToppCellMyeloid-Myeloid-C_(Cd16+_Monocyte)|Myeloid / shred on cell class and cell subclass (v4)

ACE LMX1B

1.24e-03117202d1936e76a935216783a73ab414e4147fa48e68eb
ToppCellFrontal_cortex-Macroglia-POLYDENDROCYTE-P1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

1.24e-0311720213f068cc4b4a8e9c66bf0e9e5acf9613654bf3f4
ToppCellfrontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CNKSR3 PMEL

1.28e-03119202ec3af1253f03b3ec403f73243237acf08ad56789
ToppCell3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

PRRC2C BTAF1

1.64e-03135202ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCellLPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ACE SP1

1.71e-031382025f8ac8f67e34a7cf560099208e6884102532391e
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

WDFY4 IL36G

1.74e-03139202505bf5a483fc2ba69377db9850c3b26ab2f416d1
ToppCellfacs-Marrow-B-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL36G KRT39

1.74e-0313920227dd36f5ef03fa97f0fdb19fbd259cb60e7962b3
ToppCellfacs-Marrow-B-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL36G KRT39

1.74e-031392022a54627947f8c6597c041f4785f8a4e52d0edfba
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9

MMP26 CNKSR3

1.76e-0314020282b150e9e9962460a5cd6bef7ee04f28f5c05d1a
ToppCellControl-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TIGIT WDFY4

1.89e-03145202bab85a72142b6257f7d424e5301f65b6dcdf745d
ToppCellEntopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

1.91e-03146202a317f14a1aab11ffcce65baeb1c475c04324315f
ToppCellLPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TIGIT WDFY4

1.96e-03148202cb9365663f9cba35d47b5dd9079f42e88b70d915
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ACE WDFY4

1.96e-0314820212fa2c4922f03803006c606b1b16e79441e3bb13
ToppCellPND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IL36G RESF1

1.99e-031492022a2a5673ce4f376e7b25f2bc8127fb7e260f37af
ToppCellLeuk-UTI-Lymphocyte-T_NK-dnT|Leuk-UTI / Disease, Lineage and Cell Type

TIGIT CNKSR3

1.99e-0314920253f145cf7089d948d41aa3c443e983e011826836
ToppCellPND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IL36G RESF1

1.99e-03149202c9f02ec62a658a751e591699f9395fe597e22a2e
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9

MMP26 CNKSR3

1.99e-03149202649eb3441fa859591ea85f1ed5fcf08af272a32b
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells)

TIGIT SP1

1.99e-0314920241f28138bde45d0b814e116837e5a32b5e80d54a
ToppCellSubstantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CNKSR3 PMEL

2.02e-0315020270ac8ae4b1683fb17278a8e4606f2fa0b94988c0
ToppCell3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue

PRRC2C RESF1

2.04e-03151202999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TIGIT RESF1

2.04e-03151202e1ffd99001b6a5b795f3367882a9355955c0e569
ToppCellLPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TIGIT WDFY4

2.07e-031522020c6dd41142e4ca1e54ca41e05e42ed29fbf0e570
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TIGIT RESF1

2.10e-031532027518187a5fbf6c0881182dc79bd37c2d49f92b2e
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TIGIT RESF1

2.10e-0315320293d36723f01c2df39feebf20f3eba5b4fb4cdf59
ToppCell356C-Lymphocytic-NK_cells-NK_cell_D2|356C / Donor, Lineage, Cell class and subclass (all cells)

TIGIT PMEL

2.10e-031532025fb7d92cddc816c64071465e955ed0ea3bb45316
ToppCellfacs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IL36G RESF1

2.10e-03153202338684d420b01e32918fa19048ccdda234942ce1
ToppCellLeuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type

TIGIT SP4

2.10e-03153202b24c693b142206d13b29c96faa7f79a1a22bc2ef
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TIGIT RESF1

2.10e-031532027480522a47e367f8facc4f5d599fbaf0b5ad4007
ToppCellLPS-IL1RA+antiTNF-Myeloid-Dendritic_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TIGIT WDFY4

2.10e-03153202c81a88d3f707487c511020d3960a1c41e706c6a0
ToppCellIIH-Treg|IIH / Condition, Cell_class and T cell subcluster

TIGIT RESF1

2.10e-0315320217704e18833812fcf2a2727b1e3f8a9984ba5b59
ToppCellMyeloid-F|World / shred on cell class and cell subclass (v4)

IL36G RESF1

2.12e-031542026d53eec4aefe54836bbfd314f28f5e9a24c2d833
ToppCelldroplet-Kidney-nan-18m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDFY4 IL36G

2.12e-03154202ad6cfd7fc02f4201863dc8e12e353395c86c5fdb
ToppCellIIH-Treg-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster

TIGIT RESF1

2.12e-03154202d2211a892654b92decb208969040920f7ae8ba1e
ToppCellRV-17._Lymphocyte|World / Chamber and Cluster_Paper

TIGIT RESF1

2.15e-03155202189276a3b400b2202e6681e23732e6452bfe704e
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TIGIT RESF1

2.18e-0315620253ded973358e3e48054130131e959f0d1f4ef60f
ToppCellfacs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IL36G RESF1

2.21e-031572025098675f64342c41c5ca3551b24962d10c83e64d
ToppCellfacs-Lung-24m-Hematologic-myeloid-neutrophil|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IL36G RESF1

2.21e-03157202e96241db2b5ff52b230e3e33207e7bb968900cab
ToppCellfacs-Lung-24m-Hematologic-myeloid-neutrophil-neutrophil|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IL36G RESF1

2.21e-0315720207a0f8d29a3111be670eae030a91474465eba734
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

TIGIT RESF1

2.21e-03157202f2bc60ec0305b056d79f1b7fd6b5e3730d606916
ToppCellfacs-Trachea-24m-Hematologic-myeloid-granulocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

IL36G RESF1

2.21e-03157202188d2f85babcd4eefe20e7a392d851b2e1185bab
ToppCelldroplet-Kidney-nan-18m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDFY4 IL36G

2.23e-03158202e0b862e4b9ebaa12869640b5d18d5fa852861bef
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL36G RESF1

2.23e-03158202d43b335e6aa12d84a75b988fbd6127ff1f4af25c
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL36G RESF1

2.23e-03158202ab12b29ce51ca2fcac469cc932391217d97145f9
ToppCellfacs-Limb_Muscle-forelimb_and_hindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL36G PMEL

2.26e-03159202f7803f7b4e0379ae8256ec53110833bedee7db98
ToppCellfacs-Limb_Muscle-forelimb_and_hindlimb-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL36G PMEL

2.26e-031592026e2d38e78d2ef7803e8bb154b5c788bf62a41045
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CLIP4 SP4

2.29e-03160202b2d8940ea8c068273b7da1589d3d6ae5110d8209
ToppCelldroplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDFY4 IL36G

2.29e-03160202e9e52532131cdc3fb01e81cfc046e3f670cc8e75
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CLIP4 SP4

2.29e-031602029caab1bb63c7e66c44783852ee75b16bb40fa594
ToppCellLPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TIGIT WDFY4

2.29e-03160202dee756a2dc9725520d439e7273c489c2284015d8
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CLIP4 SP4

2.29e-03160202229841be7b984a00a301cd5d88c11226a90d8a88
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CLIP4 SP4

2.29e-0316020299c9ae2041445539fada842e1af01368669bfca0
ToppCellfacs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLIP4 IL36G

2.35e-03162202593939be9d38690c89c31d4c58e351de26cbf9ab
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

TIGIT RESF1

2.35e-031622024b9f80f701dcbb2508f497095cb8a7a2ca51cb5e
ToppCellfacs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLIP4 IL36G

2.35e-031622023a61eda548afa2a41bdf6293d1050103dc210e52
ToppCell356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells)

WDFY4 SP1

2.35e-031622027d43d59531cbefe3ac94953b7faf7156b2a31441
ToppCelldroplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL36G PMEL

2.37e-03163202bc37c5d9f48b16096d5313657563f3ec84028c8c
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MMP26 IL36G

2.37e-03163202a2b124a0107b495116c3b64d4cb676f84895e1ba
ToppCellfacs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ALMS1 TIGIT

2.37e-03163202385b24e18df5ef92108483de312d6c85a1e6d145
ToppCellnormal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

TIGIT RESF1

2.37e-0316320243887e7687fc6367efac0c1f56a9534b06f47b7f
ToppCellfacs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ALMS1 TIGIT

2.37e-031632028004cc0b3428be08b89957b563cd8799f822d931
ToppCelltumor_Lung-T/NK_cells-Naive_CD8+_T|tumor_Lung / Location, Cell class and cell subclass

TIGIT RESF1

2.40e-03164202a669d3b39dcd219a1973e266765e2f2b114438ef
ToppCelldroplet-Kidney-nan-18m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TIGIT IL36G

2.40e-03164202731b9c7d6f6ecfb14d4a8705e0ddac9fb460d9a8
ToppCellChildren_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

MMP26 LMX1B

2.40e-03164202be49af6335f2505065cde2cb9800e4a5516811b1
ToppCellBAL-Mild-cDC_11|Mild / Compartment, Disease Groups and Clusters

WDFY4 CNKSR3

2.40e-031642024bd9629d054545d1e3f9e5c127b5ac2388637106
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TIGIT RESF1

2.43e-031652029ccce713d4122054bf4bef4a7126d90cf9141b84
ToppCellfacs-BAT-Fat-3m-Myeloid|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL36G RESF1

2.43e-031652028bdeacbb47948fabae2575689f811a9fad47f779
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MMP26 WDFY4

2.43e-03165202fead3f2032f8fa5f7f0159a4434989b3d65debbb
DrugSP 0

SP1 SP3 SP4

6.93e-0810203CID002742752
Drughyperoside

SP1 SP3 SP4

1.16e-0624203ctd:C021304
DrugADP-ribosylarginine

SP1 SP3 SP4

1.32e-0625203CID000126311
Drughomocysteic acid

SP1 SP3

2.20e-063202ctd:C007956
Drug3-(2-carboxyindol-3-yl)propionic acid

SP1 SP3 SP4

6.99e-0643203CID000169313
Drugpoly(tetramethylene adipate

SP3 SP4

7.32e-065202CID000032794
DrugLysylproline

ACE SP1 SP3

9.78e-0648203CID000171204
Drugdiazinane

ACE SP3

2.05e-058202CID000136334
DrugMidecamycin [35457-80-8]; Up 200; 5uM; HL60; HG-U133A

PRRC2C SETD2 YIPF2 RESF1

2.41e-051982042026_UP
DrugProglumide [6620-60-6]; Up 200; 12uM; PC3; HT_HG-U133A

MMP26 ACE LMX1B IL36G

2.46e-051992043780_UP
Drugdimethoate

SP3 SP4 BTAF1

3.19e-0571203CID000003082
DrugAC1L1B35

SP1 SP3 SP4

3.61e-0574203CID000001263
Drug1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane

SP1 SP4

4.01e-0511202ctd:C492909
DrugArg-pro

ACE SP1 SP3

4.91e-0582203CID000151003
Drugbiapenem

LMX1B PMEL

5.68e-0513202CID000071339
Drug2,4-DB

ACE SP3

6.63e-0514202CID000001489
Drugdemycarosyl-3D-digitoxosylmithramycin SK

SP1 SP3

8.73e-0516202ctd:C576677
DrugAC1MUFT5

ACE SP4

8.73e-0516202CID003640214
DrugTPEN

SP1 SP3 SP4

8.88e-05100203CID000005519
DrugDimethyl C7

SP1 SP4

1.11e-0418202CID000123994
DrugNSC24559

SP1 SP3 SP4

1.60e-04122203CID000029051
DrugSubstance P

ACE SP1 SP3 SP4

2.03e-04343204CID000036511
DrugAC1L71LQ

SP1 SP4 BTAF1

2.35e-04139203CID000327967
Drugoxybutynin

SP4 PMEL

2.73e-0428202CID000004634
Druggeldanamycin

SP4 PRRC2C SETD2 RESF1

2.73e-04371204ctd:C001277
DrugNH(2

SP3 PMEL

2.93e-0429202CID005460607
Drugcompound 48/80

ACE SP3 SP4

3.00e-04151203CID000104735
Drughomophenylalanine

MMP26 ACE

3.14e-0430202CID000102530
Drugmithramycin A

SP1 SP3

3.36e-0431202ctd:C066851
DrugAC1L1VJ1

LMX1B SP1

3.36e-0431202CID000010592
Drugdichlorprop

ACE SP3

3.81e-0433202CID000008427
Drugtolvaptan

ACE PMEL

3.81e-0433202CID000216237
Drugstatine

ACE SP3

3.81e-0433202CID000123915
DrugS-Nitrosoglutathione

SP1 SP3

4.04e-0434202ctd:D026422
DrugEledoisinum

SP3 SP4

4.04e-0434202CID000006242
DrugPhysalemin

SP3 SP4

4.29e-0435202CID000017268
Drugolmesartan medoxomil

ACE PMEL

5.33e-0439202CID000130881
DrugAG-1478; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA

ALMS1 PRRC2C SETD2

5.61e-041872031141_DN
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

CLIP4 YIPF2 PMEL

5.61e-041872031662_UP
DrugHarmine hydrochloride [343-27-1]; Down 200; 16uM; PC3; HT_HG-U133A

ALMS1 GEMIN2 SETD2

5.87e-041902035855_DN
DrugPromegestone

SP1 SP3

5.89e-0441202ctd:D011397
DrugPhenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A

ALMS1 SP4 PRRC2C

5.96e-041912034283_DN
DrugCyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A

ALMS1 PRRC2C SETD2

6.05e-041922033252_DN
DrugDosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A

ALMS1 SP1 YIPF2

6.15e-041932035986_DN
Drugikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA

ALMS1 SP1 SETD2

6.15e-04193203866_DN
DrugL-alpha-methyldopa

ACE PMEL

6.18e-0442202CID000004138
DrugHeparin Heptasaccharide

SP3 SP4

6.18e-0442202CID005289052
DrugDosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A

ALMS1 SP1 SETD2

6.24e-041942032864_DN
DrugPivampicillin [33817-20-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A

ALMS1 SP1 YIPF2

6.24e-041942033506_DN
DrugGalanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A

ALMS1 SETD2 RESF1

6.24e-041942034772_DN
Drug(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A

SP1 IL36G YIPF2

6.24e-041942034546_UP
DrugRisperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A

ALMS1 SP1 SETD2

6.33e-041952033508_DN
DrugMemantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; PC3; HT_HG-U133A

LMX1B SP1 YIPF2

6.52e-041972034017_UP
Drug2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA

SP1 SETD2 YIPF2

6.62e-041982031002_UP
DrugLevamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A

MMP26 IL36G YIPF2

6.72e-041992032257_UP
Drughaloperidol; Down 200; 10uM; MCF7; HG-U133A

ALMS1 IL36G YIPF2

6.72e-04199203418_DN
Drug0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A

ACE SP1 IL36G

6.72e-041992033777_UP
DrugDelcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A

CLIP4 LMX1B SP1

6.72e-041992036033_DN
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A

CLIP4 ACE PMEL

6.82e-042002036963_UP
DrugSparteine (-) [90-39-1]; Up 200; 17uM; HL60; HT_HG-U133A

MMP26 SP1 IL36G

6.82e-042002032134_UP
Drug(cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A

CLIP4 LMX1B SP1

6.82e-042002036049_DN
DrugMinoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HG-U133A

ALMS1 GEMIN2 SETD2

6.82e-042002031914_DN
Drugquercetin

MMP26 SP1 IL36G SETD2

7.34e-04482204CID005280343
DiseaseChronic schizophrenia

ACE SP1

1.57e-059202C0221765
Diseaseresponse to acetylsalicylate

SETD2 CNKSR3

5.21e-0516202GO_1903492
Diseaseocular sarcoidosis

PRRC2C CNKSR3 RESF1

6.43e-05116203EFO_0010723
DiseaseKidney Failure

ACE LMX1B

1.00e-0422202C0035078
DiseaseDNA methylation

ALMS1 MMP26 SP3 RESF1

8.83e-04656204GO_0006306
DiseaseParkinson disease

SP1 CNKSR3 RESF1

1.27e-03321203MONDO_0005180
DiseaseHodgkins lymphoma

ACE KRT39

1.40e-0382202EFO_0000183
Diseasecognitive function measurement, self reported educational attainment

ALMS1 SP4 BTAF1

1.69e-03355203EFO_0004784, EFO_0008354
Diseaseobsolete_red blood cell distribution width

MMP26 SP1 SP3 PRRC2C RESF1

1.72e-031347205EFO_0005192
DiseaseNeurodevelopmental Disorders

LMX1B SETD2

1.80e-0393202C1535926
DiseaseSchizophrenia

ACE LMX1B SP1 SP4

2.63e-03883204C0036341

Protein segments in the cluster

PeptideGeneStartEntry
VTQWLQEQNQQNGEV

ACE

606

P12821
VWQQIVYQGNSRTQI

ALMS1

116

Q8TCU4
QWVPQVQQNIDIIGN

CLIP4

76

Q8N3C7
VQWALQVQGNQLQTA

C5orf38

106

Q86SI9
WSNVTPLIFQQVQNG

MMP26

131

Q9NRE1
QWQQQQVAQFSTVRQ

GEMIN2

101

O14893
WFNTQIEELNQQVVT

KRT39

286

Q6A163
TINDLNQQVWTLQGQ

IL36G

26

Q9NZH8
NQQVWTLQGQNLVAV

IL36G

31

Q9NZH8
QQVQMTVTETNQEWQ

BTAF1

836

O14981
QISWQTVQVQNIQSL

SP4

466

Q02446
QQQWQNPNENVSTIG

RESF1

321

Q9HCM1
QWQQQQQQGVLPQTV

PRRC2C

686

Q9Y520
QVSWQTLQLQNLQVQ

SP1

461

P08047
QVIWVNNTIINGSQV

PMEL

101

P40967
DEVIQVNQQTVVGWQ

CNK3/IPCEF1

256

G9CGD6
DEVIQVNQQTVVGWQ

CNKSR3

256

Q6P9H4
VTWQTFQVQGVQNLQ

SP3

461

Q02447
TVQTLWQQLVAQRQQ

WDFY4

2121

Q6ZS81
TAQVTQVNWEQQDQL

TIGIT

51

Q495A1
SVWDSNQQSVSVQQQ

SETD2

2271

Q9BYW2
LQEQQQQQQPGFWTF

YIPF2

66

Q9BWQ6
TGLSVRVVQVWFQNQ

LMX1B

256

O60663